| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Apoptosis in asymptomatic HIV-1 seropositives immunized with HIV-1 env glycoprotein (gp160): Effects of administration of Zidovudine in vivo and interleukin-2 in vitro
|
Pierdominici, Marina
|
|
1998
|
16 |
7 |
p. 715-721
7 p.
|
article
|
| 2 |
Emergency vaccination of pigs against foot-and-mouth disease: protection against disease and reduction in contact transmission
|
Salt, J.S.
|
|
1998
|
16 |
7 |
p. 746-754
9 p.
|
article
|
| 3 |
Enhancement of immune response to intranasal influenza HA vaccine by microparticle resin
|
Higaki, Megumu
|
|
1998
|
16 |
7 |
p. 741-745
5 p.
|
article
|
| 4 |
Erratum
|
|
|
1998
|
16 |
7 |
p. 759-
1 p.
|
article
|
| 5 |
Field evaluation of two bait delivery systems for the oral immunization of dogs against rabies in Tunisia
|
Matter, Hans C.
|
|
1998
|
16 |
7 |
p. 657-665
9 p.
|
article
|
| 6 |
Genetically modified CELO viruses; vector for use in e.g. cytokine-mediated gene therapy, or as an antitumor etc. recombinant vaccine
|
|
|
1998
|
16 |
7 |
p. 757-
1 p.
|
article
|
| 7 |
Identification of potential CD8+ T-cell epitopes of the 19 kDa and AhpC proteins from Mycobacterium tuberculosis. No evidence for CD8+ T-cell priming against the identified peptides after DNA-vaccination of mice
|
Erb, Klaus J.
|
|
1998
|
16 |
7 |
p. 692-697
6 p.
|
article
|
| 8 |
Immunogenicity of liposome-associated and refined antigen oral cholera vaccines in Thai volunteers
|
Chaicumpa, Wanpen
|
|
1998
|
16 |
7 |
p. 678-684
7 p.
|
article
|
| 9 |
Intra nasal administration of poly-lactic acid microsphere co-encapsulated Yersinia pestis subunits confers protection from pneumonic plague in the mouse
|
Eyles, Jim E.
|
|
1998
|
16 |
7 |
p. 698-707
10 p.
|
article
|
| 10 |
LT(R192G), a non-toxic mutant of the heat-labile enterotoxin of Escherichia coli, elicits enhanced humoral and cellular immune responses associated with protection against lethal oral challenge with Salmonella spp.
|
Chong, Celeste
|
|
1998
|
16 |
7 |
p. 732-740
9 p.
|
article
|
| 11 |
Melanoma-specific immunogens of pMel-17 and tyrosinase; for use in cancer vaccine and nucleic acid vaccine
|
|
|
1998
|
16 |
7 |
p. 757-
1 p.
|
article
|
| 12 |
Mucosal immunogenicity elicited in mice by oral vaccination with phosphorylcholine encapsulated in poly (d,l-lactide-co-glycolide) microspheres
|
Allaoui-Attarki, Khadija
|
|
1998
|
16 |
7 |
p. 685-691
7 p.
|
article
|
| 13 |
Peptides from human herpes simplex virus and human cytomegalo virus; recombinant protein for use in herpes virus infection and atherosclerosis therapy
|
|
|
1998
|
16 |
7 |
p. 757-
1 p.
|
article
|
| 14 |
Recombinant pox virus containing sequence encoding myelin protein and infected cells for use in inflammatory demyelinizing disease diagnosis, therapy, gene therapy and recombinant vaccine
|
|
|
1998
|
16 |
7 |
p. 757-
1 p.
|
article
|
| 15 |
Relationship between structure and neutralizing activity of rabbit tetanus antibodies elicited by acellular and whole-cell pertussis DTP vaccines
|
Dokmetjian, José
|
|
1998
|
16 |
7 |
p. 672-677
6 p.
|
article
|
| 16 |
Role of long-persisting human hepatitis E virus antibodies in protection
|
Chauhan, A.
|
|
1998
|
16 |
7 |
p. 755-756
2 p.
|
article
|
| 17 |
Safety and immunogenicity of a combined diphtheria-tetanus-acellular pertussis-hepatitis B vaccine administered according to two different primary vaccination schedules
|
Giammanco, Giuseppe
|
|
1998
|
16 |
7 |
p. 722-726
5 p.
|
article
|
| 18 |
Safety and immunogenicity of a hepatitis B vaccine formulated with a novel adjuvant system
|
Thoelen, S.
|
|
1998
|
16 |
7 |
p. 708-714
7 p.
|
article
|
| 19 |
The effect of pertussis toxin and whole-cell pertussis vaccine on haemodynamics and autonomic responsiveness in the rat depends on route of administration and age
|
van Amsterdam, Jan G.C.
|
|
1998
|
16 |
7 |
p. 666-671
6 p.
|
article
|
| 20 |
Vaccine for enhancing T-cell response containing antigen and adjuvant acting via the CD28 receptor; antigen and monoclonal antibody or humanized antibody fusion protein expression for use as a recombinant vaccine
|
|
|
1998
|
16 |
7 |
p. 757-
1 p.
|
article
|
| 21 |
Whole-killed gp120-depleted HIV-1 antigen in a murine model for prophylactic vaccination
|
Lanza, Paola
|
|
1998
|
16 |
7 |
p. 727-731
5 p.
|
article
|
Journal description